Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
The American Journal of Medicine
|
November 1, 1973
Evaluation of intravenous calcium as therapy for osteoporosis
R J Dudl, J W Ensinck, D Baylink, et al.
Neurology
|
January 1, 1985
Chronic allopurinol and adenine therapy in Duchenne muscular dystrophy: effects on muscle function, nucleotide degradation, and muscle ATP and ADP content
T E Bertorini, G M Palmieri, J Griffin, et al.
Arthritis and Rheumatism
|
November 1, 1995
Treatment of calcinosis with diltiazem
G M Palmieri, J I Sebes, J A Aelion, et al.
AJR. American Journal of Roentgenology
|
February 1, 1984
Radiographic manifestations of aluminum-induced bone disease
J I Sebes, M L Pinstein, J D Massie, et al.
JAMA
|
July 17, 1996
Changes in bone mineral content in male athletes. Mechanisms of action and intervention effects
R C Klesges, K D Ward, M L Shelton, et al.
Neurology
|
April 1, 1988
Effect of chronic treatment with the calcium antagonist diltiazem in Duchenne muscular dystrophy
T E Bertorini, G M Palmieri, J W Griffin, et al.
The Journal of Laboratory and Clinical Medicine
|
April 1, 1985
Soft tissue calcium and magnesium content in acute pancreatitis in the dog: calcium accumulation, a mechanism for hypocalcemia in acute pancreatitis
S K Bhattacharya, R W Luther, J W Pate, et al.
Annals of Internal Medicine
|
June 1, 1986
Biliary excretion of aluminum in aluminum osteodystrophy with liver disease
J W Williams, S R Vera, T G Peters, et al.
The American Journal of the Medical Sciences
|
September 1, 1995
Octreotide enhances positive calcium balance in Duchenne muscular dystrophy
D F Nutting, E A Schriock, G M Palmieri, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
The American Journal of Medicine
|
November 1, 1973
Evaluation of intravenous calcium as therapy for osteoporosis
R J Dudl, J W Ensinck, D Baylink, et al.
Neurology
|
January 1, 1985
Chronic allopurinol and adenine therapy in Duchenne muscular dystrophy: effects on muscle function, nucleotide degradation, and muscle ATP and ADP content
T E Bertorini, G M Palmieri, J Griffin, et al.
Arthritis and Rheumatism
|
November 1, 1995
Treatment of calcinosis with diltiazem
G M Palmieri, J I Sebes, J A Aelion, et al.
AJR. American Journal of Roentgenology
|
February 1, 1984
Radiographic manifestations of aluminum-induced bone disease
J I Sebes, M L Pinstein, J D Massie, et al.
JAMA
|
July 17, 1996
Changes in bone mineral content in male athletes. Mechanisms of action and intervention effects
R C Klesges, K D Ward, M L Shelton, et al.
Neurology
|
April 1, 1988
Effect of chronic treatment with the calcium antagonist diltiazem in Duchenne muscular dystrophy
T E Bertorini, G M Palmieri, J W Griffin, et al.
The Journal of Laboratory and Clinical Medicine
|
April 1, 1985
Soft tissue calcium and magnesium content in acute pancreatitis in the dog: calcium accumulation, a mechanism for hypocalcemia in acute pancreatitis
S K Bhattacharya, R W Luther, J W Pate, et al.
Annals of Internal Medicine
|
June 1, 1986
Biliary excretion of aluminum in aluminum osteodystrophy with liver disease
J W Williams, S R Vera, T G Peters, et al.
The American Journal of the Medical Sciences
|
September 1, 1995
Octreotide enhances positive calcium balance in Duchenne muscular dystrophy
D F Nutting, E A Schriock, G M Palmieri, et al.
Page
of 6